This is consistent with the decrease in PD-L1 expression in both mouse and human KRAS-mutant lung cancer cells observed with concomitant Mitogen-activated ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) inhibition [18,19,20]. This evidence concerns the gene CD274 and lung cancer.